BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5

• Press Releases

  Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes

  September 4, 2025

   · 

  6 min read
• Press Releases

  Eisai to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025

  September 4, 2025

   · 

  4 min read
• Press Releases

  Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 3, 2025

  September 4, 2025

   · 

  1 min read
• Press Releases

  Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

  September 4, 2025

   · 

  1 min read
• Press Releases

  Atara Biotherapeutics Announces Changes to Its Board of Directors

  September 4, 2025

   · 

  2 min read
• Press Releases

  Nektar Therapeutics to Participate in Two Investor Conferences in September 2025

  September 4, 2025

   · 

  2 min read
• Press Releases

  Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing

  September 4, 2025

   · 

  5 min read
• Press Releases

  Flashpoint Therapeutics Announces Major Publication Supporting Application of its Proprietary Structural Nanomedicine Platform to CRISPR-based Therapeutics

  September 4, 2025

   · 

  3 min read
• Press Releases

  Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 3, 2025

  September 4, 2025

   · 

  3 min read
• Press Releases

  Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 3, 2025

  September 4, 2025

   · 

  2 min read